Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2025-12-26 @ 2:01 AM
Study NCT ID:
NCT00257205
Status:
COMPLETED
Last Update Posted:
2012-07-02
First Post:
2005-11-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-03
Start Date Type:
None
Primary Completion Date:
2010-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08
Completion Date Type:
ACTUAL
First Submit Date:
2005-11-18
First Submit QC Date:
None
Study First Post Date:
2005-11-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2011-05-04
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2012-06-25
Last Update Post Date:
2012-07-02
Last Update Post Date Type:
ESTIMATED